AI summary · may contain errors
TMM-based classification is the only independent prognostic factor in 366 neuroblastoma patients, with HRs of 6.4 for EFS and 29.4 for OS.
- Open access
Moving in bioRxiv, Neuro-Oncology, Cancer Research, Frontiers in Genetics, Journal of Clinical Oncology, Cell Reports, Clinical Cancer Research and EMBO Molecular Medicine.
Rebuilt
Nothing in this topic has moved yet this week.
Newest first · last 60 days
AI summary · may contain errors
TMM-based classification is the only independent prognostic factor in 366 neuroblastoma patients, with HRs of 6.4 for EFS and 29.4 for OS.
AI summary · may contain errors
A consensus State of the Science conference for NF1-related peripheral nerve sheath tumors defines “at-risk” pre-malignant lesions using combined histologic, molecular, and imaging features.
AI summary · may contain errors
Dinutuximab plus sargramostim with COG induction cycles 3–5 was feasible and tolerable in 40 newly diagnosed high-risk neuroblastoma patients, with 92.0%–101.8% of planned DIN doses delivered.
AI summary · may contain errors
Neuronal-like and secretory neuroendocrine malignant cell states were identified across 38 pancreatic and small-intestinal GEP-NETs, revealing a conserved cell-state axis.
AI summary · may contain errors
NUDT21 is substantially upregulated in neuroblastoma and, when silenced, inhibits proliferation and induces apoptosis, suppressing xenograft growth in nude mice.
AI summary · may contain errors
OKI-1546–mediated CDK12/13 inhibition induces BRCAness and apoptosis in neuroblastoma cells, and synergizes with merestinib to intensify DNA damage.
AI summary · may contain errors
HLA-A, HLA-B, and HLA-C class I and DRB1–DQB1 class II polymorphisms are linked to pediatric neuroblastoma susceptibility and outcomes, with strongest evidence for OS and PFS.
AI summary · may contain errors
Combined ATR inhibition with elimusertib plus low-dose mitotic KSP inhibition is additive to mildly synergistic and induces cell death in MYCN-amplified neuroblastoma models.
AI summary · may contain errors
Longitudinal RB1 ctDNA VAF in plasma is linked to extraocular retinoblastoma in 4/33 intraocular patients, with rising plasma VAF marking those who developed spread.
AI summary · may contain errors
tcf4 perturbation in neuroblastoma patient-derived tumoroids is linked to shifts in differentiation-like cell fate proportions, with tcf4 KO increasing chromaffin-like cells.
AI summary · may contain errors
Spatial transcriptomics across 15 human malignant peripheral nerve sheath tumors links local invasion to spatially defined immunomodulatory and dedifferentiation programs, and identifies a transformation process tied to chromosome 9p loss.
AI summary · may contain errors
A case report describes a pendulous hyperpigmented lesion with a ridged “bag-of-worms” surface in a patient with neurofibromatosis type 1, alongside multiple café-au-lait macules and axillary freckling.
AI summary · may contain errors
In neuroblastoma and hepatoblastoma models, AP-1–KDM5 chromatin rewiring increases transcriptional noise during DTP awakening, enabling MES-to-ADRN plasticity and adaptive regrowth after therapy withdrawal.
AI summary · may contain errors
MYC is linked to context-dependent metabolic programs in tumors, with diet and systemic metabolism reshaping both tumor and stromal cell metabolism across tissue and microenvironment settings.
AI summary · may contain errors
A chemotherapy-suppressed proliferative program in malignant neuroblasts predicts adverse prognosis in neuroblastoma.
AI summary · may contain errors
The ITCC-P4 platform established 353 patient-derived xenograft models from diagnostic and relapsed pediatric cancers, enabling mechanism-informed in vivo drug testing across major high-risk solid types.
AI summary · may contain errors
ACTL6A overexpression in head and neck squamous cell carcinoma coordinates AP-1 enhancer accessibility and amplifies MAPK/ERK signaling, sustaining glycolysis and hypoxic adaptation.
AI summary · may contain errors
AAV-STITCH covalently couples an anti-GD2 scFv to an AAV9-W503A capsid, enabling selective transduction of GD2-expressing neuroblastoma cells with no healthy liver transduction in pseudometastatic xenografts.
AI summary · may contain errors
Cumate-inducible neuroblastoma models show that MYC(N) activation sensitizes MYC-on cells to mitochondrial ribosome inhibitors, with marked MYC downregulation and caspase-dependent death.
Journals this month
Topics moving, week to 18 Nov 2026
By field